Bariatric Surgery Associated with a Lower Rate of Mortality Due to Infarction and Stroke

Prior bariatric surgery in a patient with morbid obesity is associated with a significant effect on survival after infarction or stroke.

TAVI: la estrategia minimalista es favorable en el EPOC severo

While these are observational data, the significant metabolic improvement experienced after the surgery can explain perfectly such findings.

This large nationwide registry of bariatric surgery found a 40% decrease in the risk of death, infarction, or stroke for these patients compared with patients who did not undergo such surgery. This benefit is still observed after individuals are matched by body mass index (BMI). There already are many small studies showing similar data for obese patients who undergo bariatric surgery. Bariatric surgery has also proven to be an effective and durable treatment for type 2 diabetes, although the mechanisms for such effect are not entirely understood.


Read also: Nonobstructive Coronary Lesions and Ventricular Dysfunction


The US bariatric surgery database sponsored by the Agency for Healthcare Research and Quality assessed 995,577 patients hospitalized for acute myocardial infarction and 917,610 for stroke over an 8-year period. Of these, 2218 patients with infarction and 2,168 with stroke had undergone prior bariatric surgery. Those patients were compared with a control group of morbidly obese patients with the same risk characteristics using propensity score matching.

Death due to infarction was 1.85% in patients with prior bariatric surgery compared with 3.03% in morbidly obese patients (p = 0.004). Similar results were observed with stroke: 1.43% vs. 2.74% (p = 0.001).

An analysis using BMI to match patients showed nearly identical results.


Read also: New Percutaneous Devices to Prevent Embolism in Atrial Fibrillation.


Bariatric surgery should have never been seen as a cosmetic procedure, but rather a tool to treat metabolic disease.

Original Title: Bariatric Surgery is Associated with a Lower Rate of Death after Myocardial Infarction and Stroke: a Nationwide Study.

Reference: Aminian A et al. Diabetes Obes Metab. 2019 May 3. [Epub ahead of print].

Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...

SMART-CHOICE 3 | Efficacy and Safety of Clopidogrel vs Aspirin Monotherapy in High Risk Patients after Percutaneous Coronary Intervention

Courtesy of Dr. Juan Manuel Pérez. After post percutaneous coronary intervention (PCI) standard duration dual antiplatelet therapy (DAPT), the optimal long term monotherapy strategy is...

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...

Measuring Post-TAVI Gradients and Their Implications: Are Invasive and Echocardiographic Assessments Comparable?

Transcatheter aortic valve implantation (TAVI) is considered the treatment of choice for a significant proportion of patients with symptomatic aortic stenosis. Outcomes have improved...

Another Blow for Intra-Aortic Balloon Pumo Counterpulsation? Randomized Study on Its Use in Chronic Heart Failure Progressing to Cardiogenic Shock

Cardiogenic shock (CS) remains a condition with extremely high mortality (around 50%). While most therapies for this pathology have been studied in CS secondary...